PortfoliosLab logoPortfoliosLab logo
BMEZ vs. MRK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BMEZ vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BlackRock Health Sciences Trust II (BMEZ) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BMEZ achieves a -1.20% return, which is significantly lower than MRK's 9.78% return.


BMEZ

1D
-0.56%
1M
2.72%
YTD
-1.20%
6M
-3.00%
1Y
8.46%
3Y*
7.10%
5Y*
-3.47%
10Y*

MRK

1D
-0.82%
1M
1.41%
YTD
9.78%
6M
13.95%
1Y
54.09%
3Y*
3.77%
5Y*
12.62%
10Y*
11.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BMEZ vs. MRK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
BMEZ
BlackRock Health Sciences Trust II
-1.20%18.69%9.54%5.07%-32.65%-6.00%48.77%
MRK
Merck & Co., Inc.
9.78%9.79%-6.26%1.01%49.42%1.75%-3.26%

Correlation

The correlation between BMEZ and MRK is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.31

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Jan 30, 2020

0.22

Fundamentals

Total Revenue (TTM)

BMEZ:

$58.97M

MRK:

$65.59B

Gross Profit (TTM)

BMEZ:

$52.95M

MRK:

$49.79B

EBITDA (TTM)

BMEZ:

$43.53M

MRK:

$22.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BMEZ vs. MRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMEZ
BMEZ Risk / Return Rank: 5555
Overall Rank
BMEZ Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
BMEZ Sortino Ratio Rank: 5252
Sortino Ratio Rank
BMEZ Omega Ratio Rank: 4949
Omega Ratio Rank
BMEZ Calmar Ratio Rank: 5757
Calmar Ratio Rank
BMEZ Martin Ratio Rank: 5959
Martin Ratio Rank

MRK
MRK Risk / Return Rank: 8787
Overall Rank
MRK Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 8787
Sortino Ratio Rank
MRK Omega Ratio Rank: 8484
Omega Ratio Rank
MRK Calmar Ratio Rank: 9090
Calmar Ratio Rank
MRK Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BMEZ vs. MRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BlackRock Health Sciences Trust II (BMEZ) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BMEZMRKDifference
Sharpe ratioReturn per unit of total volatility

-1.46

Sortino ratioReturn per unit of downside risk

-1.98

Omega ratioGain probability vs. loss probability

1.11

1.35

-0.24

Calmar ratioReturn relative to maximum drawdown

0.76

4.78

-4.03

Martin ratioReturn relative to average drawdown

1.87

12.00

-10.14

BMEZ vs. MRK - Sharpe Ratio Comparison

The current BMEZ Sharpe Ratio is 0.56, which is lower than the MRK Sharpe Ratio of 2.02. The chart below compares the historical Sharpe Ratios of BMEZ and MRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BMEZMRKDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.56

2.02

-1.46

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.17

0.54

-0.71

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.49

Sharpe Ratio (All Time)

Calculated using the full available price history

0.16

0.48

-0.32

Drawdowns

BMEZ vs. MRK - Drawdown Comparison

The maximum BMEZ drawdown since its inception was -46.19%, smaller than the maximum MRK drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for BMEZ and MRK.


Loading charts...

Drawdown Indicators


BMEZMRKDifference

Max Drawdown

Largest peak-to-trough decline

-46.19%

-68.61%

+22.42%

Max Drawdown (1Y)

Largest decline over 1 year

-11.24%

-11.37%

+0.13%

Max Drawdown (3Y)

Largest decline over 3 years

-18.41%

-43.44%

+25.03%

Max Drawdown (5Y)

Largest decline over 5 years

-46.17%

-43.44%

-2.73%

Max Drawdown (10Y)

Largest decline over 10 years

-43.44%

Current Drawdown

Current decline from peak

-20.74%

-8.50%

-12.24%

Average Drawdown

Average peak-to-trough decline

-24.17%

-18.84%

-5.33%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.55%

4.52%

+0.03%

Volatility

BMEZ vs. MRK - Volatility Comparison

The current volatility for BlackRock Health Sciences Trust II (BMEZ) is 4.99%, while Merck & Co., Inc. (MRK) has a volatility of 8.21%. This indicates that BMEZ experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BMEZMRKDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.99%

8.21%

-3.22%

Volatility (6M)

Calculated over the trailing 6-month period

11.59%

17.62%

-6.03%

Volatility (1Y)

Calculated over the trailing 1-year period

15.19%

26.92%

-11.73%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.92%

23.62%

-3.70%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.16%

22.91%

+1.25%

Dividends

BMEZ vs. MRK - Dividend Comparison

BMEZ's dividend yield for the trailing twelve months is around 10.78%, more than MRK's 2.89% yield.


PositionTTM20252024202320222021202020192018201720162015
BMEZ
BlackRock Health Sciences Trust II
10.78%12.43%11.74%10.80%11.28%6.51%3.14%0.00%0.00%0.00%0.00%0.00%
MRK
Merck & Co., Inc.
2.89%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%

Financials

BMEZ vs. MRK - Financials Comparison

This section allows you to compare key financial metrics between BlackRock Health Sciences Trust II and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
24.46M
16.29B
(BMEZ) Total Revenue
(MRK) Total Revenue
Values in USD except per share items

Frequently Asked Questions


BMEZ and MRK have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MRK has higher volatility (8.21%) compared to BMEZ (4.99%). In terms of maximum drawdown, BMEZ dropped -46.19% vs MRK's -68.61%.

MRK currently has the higher Sharpe Ratio (2.02 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BMEZ and MRK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer